Posted in
Parkinsons
Review of motor cortex effects of Parkinson disease published
Dr. David Vaillancourt from the University of Florida and Dr. Roxana Burciu from University of Delaware published a review of what different brain imaging techniques have been showing when looking at the primary motor cortex in Parkinson disease patients. The effects of Parkinson disease on the substantia nigra and related…
Short & Long Term effects of DBS discussed at World Parkinson Congress
Dr. Michael Okun presented “DBS Outcomes: What can you expect in the short term and the long term?” at the 2016 World Parkinson Congress. To watch: Click here to register Choose September 21st Click Dr. Okun’s talk in the list There are lots of other great talks on that…
UF Health is National Parkinson Foundation Center of Excellence for 13th consecutive year
This designation is reserved for elite care programs that incorporate experienced, expert care with patient outreach and research endeavors, and a consistent commitment to quality care.
Dr. Christopher Hess discusses Parkinson disease on C-SPAN
Dr. Christopher Hess appeared on C-SPAN show Washington Journal for about 40 minutes to discuss Parkinson disease in the United States with the host and answer questions from callers. Dr. Hess is a neurologist in our Center and also directs the Veterans Administration Parkinson’s Disease Consortium Center…
Remembering Muhammad Ali and his impact on Parkinson care and research
Muhammad Ali will be remembered for a great many things in and out of the boxing ring. In addition to those things, we at the UF Health Center for Movement Disorders and Neurorestoration were impressed with how he lived with Parkinson disease and did so in such a public way.
Parkinson’s progression biomarker covered in UF Explore Magazine
Researchers at the University of Florida have discovered a way to measure the progression of Parkinson disease through brain imaging. See our original post on this research here. This discovery was also discussed on page 4 of the UF Explore research magazine. This new brain imaging…
Learn about 10 Parkinson’s Breakthroughs in Dr. Okun’s book
Progress is being made on various fronts in the understanding and treatment of Parkinson's Disease.
Nilotinib (Tasigna) for Parkinsons: Questions and Answers
Nilotinib (Tasigna) for Parkinsons: Questions and Answers. What is nilotinib (Tasigna)? Nilotinib is a FDA approved cancer drug for approved for use in certain types of chronic leukemia. Nilotinib is a protein kinase inhibitor that works by blocking abnormal protein signals which tell cancer cells to divide and multiply. The…